Почетна › Рак (све врсте) › Јута › Salt Lake City
Kliničke studije za Рак (све врсте) u gradu Salt Lake City, UT
25 studija za Рак (све врсте) traži učesnike na lokacijama u gradu Salt Lake City i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Childhood Cancer Predisposition Study (CCPS)
Тражи се учесникОпсервациона студија
- Primary Children's Hospital, Salt Lake City
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Тражи се учесникФаза 3
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Тражи се учесникФаза 3
- Utah Cancer Specialists Cancer Center - Medical Oncology, Salt Lake City
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Тражи се учесникФаза 2/3
- University of Utah - Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare - LDS Hospital, Salt Lake City
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Тражи се учесникФаза 1/2
- Intermountain - Primary Children's Hospital ( Site 4014), Salt Lake City
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Тражи се учесникФаза 1/2
- Huntsman Cancer Institute /ID# 271618, Salt Lake City
Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
Тражи се учесник
- University of Utah Huntsman Cancer Institute (HCI), Salt Lake City
- University of Utah Primary Children's Hospital, Salt Lake City
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Тражи се учесникФаза 1/2
- Huntsman Cancer Institute /ID# 272575, Salt Lake City
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Тражи се учесникФаза 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Тражи се учесникФаза 1/2
- Intermountain - Primary Children's Hospital ( Site 3014), Salt Lake City
SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care
Тражи се учесник
- Huntsman Cancer Institute/ University of Utah, Salt Lake City
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Тражи се учесникФаза 2
- Intermountain Healthcare, Salt Lake City
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Тражи се учесникФаза 2
- Huntsman Cancer Institute - University of Utah Health, Salt Lake City
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Тражи се учесникФаза 1/2
- Huntsman Cancer Institute, Salt Lake City
Project: Every Child for Younger Patients With Cancer
Тражи се учесникОпсервациона студија
- Primary Children's Hospital, Salt Lake City
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Тражи се учесникФаза 3
- University of Utah, Salt Lake City
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Тражи се учесник
- VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Тражи се учесникФаза 2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Тражи се учесник
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Improving Health Insurance Literacy Among Young Adult Cancer Survivors
Тражи се учесник
- University of Utah, Salt Lake City
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
Тражи се учесник
- Huntsman Cancer Institute, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, Salt Lake City
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Тражи се учесникОпсервациона студија
- Utah Cancer Specialists, Salt Lake City
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Тражи се учесник
- Huntsman Cancer Institute (The University of Utah), Salt Lake City
Studije za Рак (све врсте) u drugim gradovima
- Houston, TX124 студија
- New York City, NY105 студија
- Boston, MA90 студија
- Los Angeles, CA73 студија
- Nashville, TN65 студија
- Durham, NC61 студија
- Washington, DC60 студија
- Philadelphia, PA57 студија
- Arlington, VA52 студија
- Chicago, IL51 студија
- St. Louis, MO51 студија
- Atlanta, GA49 студија
Ostale studije u gradu Salt Lake City
- Немалоклетни карцином плућа31 студија
- Рак дојке27 студија
- Колоректални карцином22 студија
- Многи мијелом22 студија
- Рак јајника19 студија
- Рак плућа19 студија
- Меланом19 студија
- Метастатски карцином17 студија
- Затајење срца17 студија
- Akutna mijeloidna leukemija17 студија
- Гојазност16 студија
- Карцином ендометријума15 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.